Evaluation of Five Novel Intervention Components in Online Obesity Treatment: Outcomes of a Randomized Factorial Experiment
Obesity · 2025
DOI: 10.1002/oby.70039 ↗At a glance
Randomisierte kontrollierte Studie in Obesity, 2025. Written by J Graham Thomas and 8 co-authors. Institution: Weight Control and Diabetes Research Center, The Miriam Hospital, Providence, Rhode Island, USA. Major MEDLINE topics: Obesity, Weight Reduction Programs, Behavior Therapy. Cited 5 times so far (Crossref); 50 references. Funded by: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (original language)
Objective
This study aimed to optimize weight loss outcomes in an online behavioral obesity treatment program by evaluating the effects of five novel intervention components using a factorial experiment informed by the multiphase optimization strategy framework.
Methods
A randomized factorial experiment tested 12‐month weight loss resulting from an established online obesity treatment program with randomization to zero to five novel intervention components (interactive video feedback, tailored intervention to promote physical activity, skills for dysregulated eating, virtual reality skills training, and social support with friendly competition).
Results
Adults ( N = 384; 83% female, 12% male, 5% another sex/gender or did not disclose; 23% racial and/or ethnic minority) with (mean ± SD) age of 53.5 ± 11.7 years and BMI of 35.0 ± 6.1 kg/m 2 were randomized. No intervention component independently improved weight loss ( p values > 0.199). Interaction terms ( p values < 0.01) suggest the combination of interactive video feedback, skills for dysregulated eating, and social support with friendly competition improved weight loss. Mediation analysis indicated that social support and dysregulated eating interventions influenced weight loss outcomes through improvements in social support for physical activity and dietary quality.
Conclusions
This study identified a combination of intervention components that may improve weight loss outcomes compared to the established online treatment program. Trial Registration: ClinicalTrials.gov identifier NCT04520256.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Weight Control and Diabetes Research Center, The Miriam Hospital, Providence, Rhode Island, USA.
- Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
- Center for Obesity Research, Innovation and Education, Digestive Health Institute, Hartford HealthCare, Hartford, Connecticut, USA.
- Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA.
- Center for Weight, Eating, and Lifestyle Science, Drexel University, Philadelphia, Pennsylvania, USA.
- Department of Psychological and Brain Sciences, Drexel University, Philadelphia, Pennsylvania, USA.
ORCID profiles: Carly M Goldstein, Dale S Bond, Meghan L Butryn
Funding
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Cite
APA
Thomas, J. G., Goldstein, C. M., Bond, D. S., Lillis, J., Hekler, E., Goldstein, S. P., Butryn, M. L., Cao, Z., & Wing, R. R. (2025). Evaluation of Five Novel Intervention Components in Online Obesity Treatment: Outcomes of a Randomized Factorial Experiment. Obesity. https://doi.org/10.1002/oby.70039
Vancouver
Thomas JG, Goldstein CM, Bond DS, Lillis J, Hekler E, Goldstein SP, et al. Evaluation of Five Novel Intervention Components in Online Obesity Treatment: Outcomes of a Randomized Factorial Experiment. Obesity. 2025. doi:10.1002/oby.70039
BibTeX
@article{Thomas2025,
author = {Thomas, J Graham and Goldstein, Carly M and Bond, Dale S and Lillis, Jason and Hekler, Eric and Goldstein, Stephanie P and Butryn, Meghan L and Cao, Zihuan and Wing, Rena R},
title = {Evaluation of Five Novel Intervention Components in Online Obesity Treatment: Outcomes of a Randomized Factorial Experiment},
journal = {Obesity},
year = {2025},
doi = {10.1002/oby.70039}
}
EUVIMED